16 results

  • Filters
  • Sort by
    ...
  • 5 Amino 1MQ 10MG

    5 Amino 1MQ 10MG is a 10 milligram format of 5 amino 1 methylquinolinium, commonly referenced in research as a small molecule NNMT inhibitor. Researchers study it in the context of nicotinamide N methyltransferase activity, methylation related pathways, and cellular metabolism. Studies have examined NNMT inhibition in preclinical systems involving energy balance, adipocyte biology, and NAD related chemistry.

    Add to Quote Request

    In Stock

  • 5 Amino 1MQ 50MG

    5 Amino 1MQ 50MG is a 50-milligram format of 5-amino-1-methylquinolinium (5-amino-1MQ), a small-molecule compound studied as an NNMT inhibitor in laboratory research. Studies have examined NNMT inhibition in relation to cellular methylation balance, NAD metabolism, and broader metabolic signaling pathways.

    Add to Quote Request

    In Stock

  • 5-Amino-1MQ 5MG

    5-Amino-1MQ 5MG is a 5-milligram format of 5-Amino-1MQ, a small molecule commonly used in research as an NNMT inhibitor. Researchers study NNMT inhibition in the context of cellular NAD metabolism, methylation pathways, and metabolic regulation. Studies have examined 5-Amino-1MQ in preclinical systems focused on adipose biology and energy balance.

    Add to Quote Request

    In Stock

  • Aod9604 5MG

    Aod9604 5MG is a 5-milligram format of AOD9604, a synthetic peptide analogue based on the human growth hormone fragment 176 191. Researchers study it for its potential role in metabolism and lipolysis related pathways in preclinical models. Studies have also examined AOD9604 in the context of adipose tissue signaling and body composition research.

    Add to Quote Request

    In Stock

  • Cagrilintide + Semaglutide 10MG

    Cagrilintide + Semaglutide 10MG is a 10-milligram peptide pair combining cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist peptide. Researchers study these peptides in metabolic research, including appetite signaling and glucose regulation pathways. This paired format is used in experimental designs that examine co-agonism and complementary endocrine signaling.

    Add to Quote Request

    In Stock

  • Cagrilintide + Semaglutide 5MG

    Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.

    Add to Quote Request

    In Stock

  • Cagrilintide 10MG

    Cagrilintide 10MG is a 10-milligram format of cagrilintide, a long acting amylin analogue peptide designed to engage amylin receptor pathways. Researchers study cagrilintide in preclinical and translational settings involving appetite signalling, gastric emptying models, and metabolic regulation.

    Add to Quote Request

    In Stock

  • Cagrilintide 5MG

    Cagrilintide 5MG is a 5-milligram format of cagrilintide, a long acting amylin analogue peptide engineered for extended receptor activity. Researchers study amylin analogues in the context of metabolic signaling, appetite regulation pathways, and gastric emptying models.

    Add to Quote Request

    In Stock

  • Mazdutide 10MG

    Mazdutide 10MG is a 10-milligram format of mazdutide, a synthetic peptide investigated as a dual agonist at the GLP-1 receptor and glucagon receptor. Researchers study Mazdutide 10MG in metabolic research, including models examining energy balance, glucose regulation, and body weight pathways.

    Add to Quote Request

    In Stock

  • Mazdutide 5MG

    Mazdutide 5MG is a 5-milligram format of mazdutide, a synthetic peptide studied as a dual GLP 1 and glucagon receptor agonist. Researchers have investigated it in preclinical and early clinical research related to metabolic regulation, energy balance, and glucose homeostasis. Its dual receptor profile makes it a common comparison point in incretin and glucagon pathway studies.

    Add to Quote Request

    In Stock

  • Retatrutide 10MG

    Retatrutide 10MG | Synthetic Peptide Agonist is a 10-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist in metabolic research. Studies have examined retatrutide in the context of incretin and glucagon pathway signaling using preclinical and clinical models.

    Add to Quote Request

    In Stock

  • Retatrutide 15MG

    Retatrutide 15MG is a 15-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist in metabolic research. Studies have examined retatrutide in the context of incretin and glucagon signaling pathways, including receptor activity linked to energy balance. Researchers commonly use it in controlled laboratory settings where peptide receptor pharmacology is evaluated.

    Add to Quote Request

    In Stock

  • Retatrutide 20MG

    Retatrutide 20MG is a 20-milligram format of retatrutide, a synthetic incretin-mimetic peptide designed for multi-receptor research. Studies have examined retatrutide in preclinical and clinical settings involving GLP-1, GIP, and glucagon receptor signaling and downstream metabolic endpoints.

    Add to Quote Request

    In Stock

  • Retatrutide 24MG

    Retatrutide 24MG is a 24-milligram format of retatrutide, a synthetic peptide investigated as a multi incretin receptor agonist in metabolic research. Studies have examined retatrutide in preclinical and clinical contexts involving glucose regulation, energy balance, and body weight biology.

    Add to Quote Request

    In Stock

  • Retatrutide 30MG

    Retatrutide 30MG is a 30-milligram format of retatrutide, a synthetic multi receptor agonist peptide investigated as a tri agonist at GLP 1, GIP, and glucagon receptors. Researchers study retatrutide 30MG in the context of metabolic signaling, appetite regulation pathways, and energy balance in preclinical and clinical research settings.

    Add to Quote Request

    In Stock

  • Retatrutide 36MG

    Retatrutide 36MG is a 36-milligram format of retatrutide, a synthetic peptide agonist studied for its activity across multiple metabolic hormone receptor pathways. Researchers investigate retatrutide in preclinical and clinical settings focused on energy balance, glycemic control, and body weight regulation. Its multi-target design makes it a common comparator in studies of incretin and glucagon signaling.

    Add to Quote Request

    In Stock

Filters
Brands
Product Categories
My Cart
Categories